Our study indicates that the expression and presentation of molecules like HLA‐G, which promote the formation of high‐affinity NKG2A ligands could not only represent an immune evasion strategy for tumours, but also a potential resistance mechanism in therapies with ICIs targeting NKG2A [41]. This evidence concerns the gene HLA-G and neoplasm.